<DOC>
	<DOCNO>NCT01475318</DOCNO>
	<brief_summary>By use combination mifepristone ( anti-progestin ) , misoprostol ( progstanglandin stimulates uterine contraction ) , letrozole ( aromatise inhibitor reduces estrogen production ) , abortion process effective .</brief_summary>
	<brief_title>Study Combined Use Letrozole , Mifepristone Misoprostol Termination Pregnancy</brief_title>
	<detailed_description>After mifepristone approve United States Food Drug Administration 2000 , combination mifepristone 200 mg vaginal use misoprostol 800 mcg become almost standard care early medical abortion 63 day gestation . Misoprostol , synthetic analogue naturally occur prostaglandin E1 , uterotonic effect stimulate myometrial contraction cause cervical ripen dilatation . Progesterone maintain uterus quiescent state induce hyperpolarization membrane myometrial cell great change electric potential necessary contraction occur . Mifepristone anti-progestin bind progesterone receptor prevent endogenous progesterone exert effect . It also increase sensitivity uterus prostaglandin . The complete abortion rate achieve sequential regimen find 93-95 % , high rate achieve either mifepristone misoprostol alone . Apart progesterone , estrogen another important hormone maintenance pregnancy . Albrecht et al show 50 % baboon miscarry maternal estrogen synthesis suppress use aromatase inhibitor whereas maintain pregnancy concomitant estradiol give . Letrozole third-generation aromatase inhibitor lead reduce production estrogen specific action clinical dos effect basal level cortisol aldosterone . Shi et al find combination anti-progestin aromatase inhibitor act synergistically induce 100 % abortion rate rat , little effect antiprogestin aromatase inhibitor administer alone . Lee et al conduct first pilot study effect letrozole medical abortion 9 week gestation human . When 7.5 mg letrozole combine 200 mg mifepristone , abortion effect great observe animal study , clinical complete abortion rate 71 % . On hand , 7.5 mg letrozole give daily 2 day follow 800 mcg vaginal misoprostol , regimen associate clinical complete abortion rate 80 % 87.5 % gestation le 63 day gestation le 49 day respectively . Hormonal profile reveal letrozole lead significant reduction oestradiol level , progesterone level alter . The complete abortion rate achieve note high dosage duration letrozole increase 10 mg 3 day . There serious complication encounter 200 subject , imply regimen likely safe use human . Letrozole play role medical termination principal effect oestrodial synthesis , important factor maintenance early pregnancy . It postulate combine letrozole mifepristone , together misoprostol , synergistic effect exert depleted estrogen progesterone level insufficient support pregnancy , uterotonic effect misoprostol hasten abortion process , hence improve complete abortion rate . The aim pilot study determine complete abortion rate vaginal misoprostol give mifepristone letrozole termination first trim pregnancy 9 week gestation .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>good general health old age legal consent ( i.e . &gt; 18 year old ) request medical abortion eligible abortion Day 1 study ( day letrozole mifepristone administration ) duration pregnancy 63 day confirm pelvic ultrasound examination intrauterine pregnancy ( intrauterine amniotic sac see US ) willing use hormonal intrauterine contraception first menses termination pregnancy treatment fail agree termination pregnancy surgical method willing able participate study explain haemoglobin high 10g/L , normal liver renal function history evidence adrenal pathology , steroiddependent cancer , porphyria , diastolic pressure 95mm Hg , bronchial asthma , arterial hypotension history evidence thromboembolism , severe recurrent liver disease pruritus pregnancy regular use prescription drug admission study presence IUCD utero breastfeed multiple pregnancy heavy smoker 20 cigarette per day abnormal value pretreatment blood test</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>complete abortion rate</keyword>
	<keyword>side effect</keyword>
	<keyword>induction-to-abortion interval</keyword>
</DOC>